Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant
Abstract: Posttransplant lymphoproliferative disorders (PTLD) are rare complications of solid organ transplantation, which carry significant morbidity and mortality. Phase 2 trials that use sequential rituximab (R) followed by R, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) ha...
Saved in:
| Main Authors: | Brian Cuzzo, Maegan Ford, Saagar Jain, Hua-Jay Cherng, Evelyn Orlando, Patrick Gould, Amy Song, Benjamin May, Yuxuan Chen, Govind Bhagat, Andrew H. Lipsky, Barbara Pro, Jennifer E. Amengual |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000299 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma
by: Mohammad Ma'koseh, et al.
Published: (2025-12-01) -
319 Exploring late effects care for PTLD survivors using the consolidated framework for implementation research
by: Mary Claire, et al.
Published: (2025-04-01) -
CAR‐T Cell Therapy for PTLD: Analysis of CAR‐T Product, Engraftment, and Outcomes in Patients Receiving Parallel Immunosuppression
by: Aikaterini Panopoulou, et al.
Published: (2025-02-01) -
The Case for the Anthropocene Epoch Is Stronger Than the Case for the Holocene Epoch
by: Alasdair Skelton, et al.
Published: (2025-05-01) -
WCN24-740 WT1 VARIANTS: A NEW RISK FACTOR FOR PTLD (POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE)?
by: Paulo Cesar Koch Nogueira, et al.
Published: (2024-04-01)